Identifying genes and loci for complex diseases: Examples from primary open angle glaucoma and schizophrenia
by Woodroffe, Jennifer Abigail, Ph.D., UNIVERSITY OF MICHIGAN, 2009, 112 pages; 3382476

Abstract:

This purpose of this dissertation is to progress towards identification of disease genes and loci for primary open-angle glaucoma (POAG) and schizophrenia. In studying schizophrenia, we conducted a genome-wide linkage scan in 479 subjects from 129 Afrikaner families; Afrikaners are a founder population from South Africa. Conducting a MOD score analysis, we were able to replicate a schizophrenia locus on chromosome 13q34 in subjects with broadly defined schizophrenia, which includes schizoaffective disorder-depressive subtype and schizoaffective disorder-bipolar subtype (MOD score = 3.76). We also detected a locus on chromosome 1p36 in subjects classified with a more narrowly defined form of schizophrenia that include schizoaffective disorder-depressive subtype, but not bipolar subtype (MOD score = 3.21).

We conducted two separate studies looking for POAG genes and loci. In the first study, we replicated the GLC1I locus on chromosomes 15g11-13. We initially tested 167 European American individuals in 25 multiplex open-angle glaucoma families and detected a LOD score of 1.01 at 14.3 cM. However when we used ordered subset analysis, we found that by including only the 14 families with earlier average ages at diagnosis (average = 50.6 years ± 5.4 years), there is evidence for linkage to GLC1I (LOD score = 2.09; p-value = 0.021).

In the third and final study, we tested whether glaucoma severity is associated with variants in the promoter region of a known glaucoma gene, myocilin (MYOC). There have been conflicting reports regarding the relationship between glaucoma severity and the -1000CG MYOC promoter SNP, also designated mtl. This study tested for an association in subjects from the Collaborative Initial Glaucoma Treatment Study (CIGTS); a longitudinal study where the subjects were reevaluated every six months. We found that there was not evidence for an association between -1000CG and visual field mean deviation (p=0.98) or intraocular pressure (p=0.52) across the study period in the CIGTS population. There was also no evidence of association between two other MYOC promoter SNPs, -1075GA and -1081AG, and mean deviation or intraocular pressure.

In describing these studies, this dissertation illustrates methods and techniques that can be applied to the study of the genetics of other complex diseases.

 
AdviserJulia E. Richards
SchoolUNIVERSITY OF MICHIGAN
SourceDAI/B 70-10, p. , Dec 2009
Source TypeDissertation
SubjectsGenetics; Epidemiology
Publication Number3382476
Adobe PDF Access the complete dissertation:
 

» Find an electronic copy at your library.
  Use the link below to access a full citation record of this graduate work:
  http://gateway.proquest.com/openurl%3furl_ver=Z39.88-2004%26res_dat=xri:pqdiss%26rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation%26rft_dat=xri:pqdiss:3382476
  If your library subscribes to the ProQuest Dissertations & Theses (PQDT) database, you may be entitled to a free electronic version of this graduate work. If not, you will have the option to purchase one, and access a 24 page preview for free (if available).

About ProQuest Dissertations & Theses
With over 2.3 million records, the ProQuest Dissertations & Theses (PQDT) database is the most comprehensive collection of dissertations and theses in the world. It is the database of record for graduate research.

The database includes citations of graduate works ranging from the first U.S. dissertation, accepted in 1861, to those accepted as recently as last semester. Of the 2.3 million graduate works included in the database, ProQuest offers more than 1.9 million in full text formats. Of those, over 860,000 are available in PDF format. More than 60,000 dissertations and theses are added to the database each year.

If you have questions, please feel free to visit the ProQuest Web site - http://www.proquest.com - or call ProQuest Hotline Customer Support at 1-800-521-3042.